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Abstract. Recent advances in smart glasses, wearable computers in the form of glasses, bring new therapeutic and monitoring
possibilities for people with Parkinson’s disease (PD). For example, it can provide visual and auditory cues during activities
of daily living that have long been used to improve gait disturbances. Furthermore, smart glasses can personalize therapies
based on the state of the user and/or the user environment in real-time using object recognition and motion tracking. To provide
guidelines for developers in creating new PD applications for smart glasses, a self-reported questionnaire was designed to survey
the requirements, constraints, and attitudes of people with PD with respect to this new technology. The survey was advertised
online over an 11 month period on the website of the Parkinson Vereninging. The results were derived from 62 participants
(54.8% men and 45.2% women, average age of 65.7 ± 9.1), representing a response rate of 79.5%. The participants were overall
very enthusiastic about smart glasses as an assistive technology to facilitate daily living activities, especially its potential to self-
manage motor problems and provide navigational guidance, thereby restoring their confidence and independence. The reported
level of usage of mobile technologies like tablets and smartphones suggests that smart glasses could be adopted relatively easily,
especially by younger people with PD. However, the respondents were concerned about the cost, appearance, efficacy, and
potential side effects of smart glasses. To accommodate a wide range of symptoms, personal preferences, and comfort level with
technology, smart glasses should be designed to allow simple operation and personalization.
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INTRODUCTION
Due to the impaired ability of the basal ganglia to
coordinate automatic movement sequences [1], many
people with Parkinson’s disease (PD) suffer from gait
and balance disturbances [2], characterized by small
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shuffling steps, bradykinesia, freezing, and falling
[3–7]. As these problems can persist in spite of optimal
drug treatments and deep brain stimulation, alternative
rehabilitation therapies are required [8]. Interestingly,
people with PD who typically have difficulty perform-
ing simple movements (e.g. walking) may perform
complex tasks easily in the presence of an external sen-
sory cue (e.g. cycling) [9]. For this purpose, a cue is
defined as an external temporal or spatial stimulus that
facilitates movement initiation and continuation [10].
In particular, audiovisual stimuli such as transverse
lines on the floor [11, 12] or the beat of a metronome
[10, 13–15] can greatly improve walking quality and
decrease freezing. In a large-scale multi-site clini-
cal trial of a cueing training program at home, the
participants showed improvements immediately after
intervention; however, improvements decreased con-
siderably 4–12 weeks after training [16, 17]. To
maintain the progress achieved with cueing training
and to provide cueing on demand, it is thus essen-
tial that we develop cueing devices that are effective,
portable and convenient for everyday use outside the
laboratory [10, 18].
Recent advances in mobile technology offer
promising new ways to provide external cueing and
other e-health applications (apps) to people with PD,
notably through smart glasses such as the Google
Glass, Vuzix M100, and Epson Moverio BT-200 [19].
These wearable computers are worn like conventional
spectacles but provide all the conveniences of a smart
phone. For example, smart glasses can respond to voice
and gestures commands and provide auditory feed-
back. The embedded camera can capture information
about the user environment while GPS, Wi-Fi, and iner-
tial sensors can be used to track the user’s position
and movement. Most importantly, smart glasses can
augment reality by overlaying pertinent information
derived from these sensors on top of the user’s visual
field. Given its portability, inconspicuousness, and user
friendliness, smart glasses represent an ideal modality
to provide personalized feedback and assistance to
people with PD in daily living situations. Indeed,
according to a short proceedings report by McNaney
et al. [20], participants with PD (n = 5) were generally
positive about the Google Glass as an everyday assis-
tive device; however usability issues and social stigma
still hinder its general acceptance. In developing smart
glasses and associated apps for PD, one must therefore
account for the specific requirements and constraints of
the target group and their environment. Here we report
the results of a nationwide survey in the Netherlands
on the therapeutic needs and ergonomic preferences of
people with PD and their attitudes toward adopting this
new technology.
MATERIALS AND METHODS
In accordance with the guidelines of the Declaration
of Helsinki and the ethical standards of the local med-
ical ethics committee, we conducted an online survey
of people with PD in the Netherlands to uncover pub-
lic opinions about smart glasses and how such devices
may contribute to the quality of life for people living
with PD. All research subjects participated voluntary
without monetary solicitation and provided written
informed consent for inclusion in the study.
Survey design
The initial version of the user survey was developed
based on Burgess’ guidelines on the design of sur-
veys [21] and in consultation with two neurologists,
two physical therapists, and a human movement sci-
entist who work with people with PD. To optimize
its readability and understandability, further revisions
were made to the questionnaire based on the evalua-
tions of a physical therapist with a user panel consisting
of individuals with PD.
User questionnaire
The questionnaire consisted of multiple choice ques-
tions (with the option to fill in an unlisted answer),
Likert rating scales (0 to 10), and open ended questions,
designed to gather information about the participants
(e.g. demographics, PD related difficulties, and current
use of mobile technology) and to explore their ideas and
opinions about smart glasses and its potential features.
In the introduction leading to the online survey, we
clearly described the general features of smart glasses
(e.g. augmented reality, embedded camera, movement
sensors, loudspeaker, microphone, GPS, etc.) and the
effects of external cueing (e.g. metronome and stripes
on the floor) for people with PD. The specific ques-
tions in the survey can be found in Supplement 1 and
are addressed individually in the results section. Not all
questions were required to be answered.
Data collection
The questionnaire was advertised via the website
of the Dutch society for people with PD (Parkin-
son Vereniging, www.parkinson-vereniging.nl). There
were no inclusion or exclusion criteria for participa-
tion except that respondents should be diagnosed with
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PD. The response rate during the data collection period
(Jan 22 – Dec 27, 2014) was 79.5%, based on the total
number of visitors to the survey invitation webpage
(n = 78).
Data analysis
The responses were independently reviewed and cat-
egorized by two researchers. Multiple submissions by
the same participant were accounted for by comparing
the subject data and using the most recent responses.
Disagreements about the categorization of answers to
open-ended questions were resolved through discus-
sion between the two reviewers. All data was coded and
inputted into Microsoft Excel and further data analysis
was performed using MATLAB R2012a (Mathworks,
Inc., Natick, MA, USA). Tabulated responses were
represented as a percentage of the total number of
participant responses (n). Numerical ratings were
characterized by the mean ± standard deviation (SD),
median, and skewness and their distributions com-
pared using a two-sided Kolmogorov-Smirnov (KS)
test with Bonferroni correction. Spearman’s rank cor-
relation coefficient (rs) was used to measure statistical
dependence between two variables and its effect size
was interpreted according to Cohen’s guidelines [22].
A significance level of = 0.05 was used for all statis-
tical tests.
RESULTS
Demographics
62 persons (54.8% men and 45.2% women)
responded to the survey. On average, the respondents
were 65.7 ± 9.1 years old (n = 61, range: 39–87) and
have been diagnosed with PD for 9.5 ± 6.8 years
(n = 60, range: 2–36). 86.9% cohabitate with a partner,
while 9.8% live alone and 3.3% reported other living
arrangements (n = 61). The participants represented a
variety of occupations, educational background, and
technical proficiency.
Opinions on smart glasses
We assessed whether people with PD would wel-
come smart glasses as an everyday assistive device by
asking the participants to rate how willing they were
to use smart glasses in various situations on a scale of
0 to 10 (0 corresponding to completely uncomfortable
and 10 to extremely comfortable). The ratings distribu-
tions for use at home (n = 52), outdoors (n = 51), in busy
areas (n = 52), and in general (n = 52) were centered
around 6–8 and left-skewed (i.e. the distribution is
concentrated on the right), indicating that participants
were overall receptive towards wearing smart glasses
(Fig. 1A-D). No statistically significant differences
were found amongst the ratings distributions for the
four situations, nor were there significant correlations
between the ratings and the participants’ age or the
number of years they had PD. Since smart glasses are
relatively new to the consumer market, 4 participants
explicitly indicated that they could not choose an exact
rating while 8 others indicated that they required more
hands on experience to make a precise decision. 5 par-
ticipants expressed concerns about multitasking with
smart glasses, namely that “people with PD can only do
one thing at a time and might become disoriented . . . ”
by the extra sensory information provided by smart
glasses. This was particularly worrisome in busy envi-
ronments and may exacerbate their motor and cognitive
disabilities. On the other hand, 3 respondents described
smart glasses as an ideal therapeutic tool for PD. ‘It was
the first thing that came into my mind when I heard
about the Google Glass,” recounted one participant.
Indeed, 80.7% of the respondents (n = 62) were will-
ing to participate in a clinical trial to further test the
functionalities and efficacy of such devices.
We also asked participants to list the features
they would like to see in smart glasses and cat-
egorized their responses into three subcategories:
function, design, and applications (Table 1). First,
respondents most frequently requested features for
improving the quality of their gait and maintaining
balance, thereby allowing them to gain more inde-
pendence and confidence. Equally important was that
side effects (e.g. headaches, dizziness, disorientations,
eye strain, etc.) be minimal. Design wise, the control
interface must be easy to operate, especially for the
elderly, and allow hands-free operation. Furthermore,
the device should be comfortable to wear, aesthet-
ically pleasing, and compatible with prescription
glasses. Besides the basic smart phone applications
(e.g. GPS, calendar, address book, media player, etc.),
the participants desired more specialized PD func-
tions such as guide-dog like navigational guidance and
object avoidance, external cueing (e.g. metronome,
music, and stripes on the floor), real-time detection
of motor fluctuations, warnings or instructions on
how to improve performance, medication alerts, and
logging of daily activities. One participant even sug-
gested using smart glasses to provide virtual reality
physiotherapy.
We further surveyed how much people with PD were
willing to pay (out of pocket) for such a device. The per-
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Fig. 1. Smart glasses and Parkinson’s disease in daily living situations. (A-D) Ratings of how comfortable people with PD are in using smart
glasses (A) in general (n = 52), (B) at home (n = 52), (C) outdoors (n = 51), and (D) in busy areas (n = 52). (E-G) Ratings of how severely PD
hinders people with PD (E) at home (n = 61), (F) at work (n = 37), and (G) in daily life (n = 62). The rating scale ranged from 0 to 10, with 0
corresponding to extremely uncomfortable (A-D) or nondisruptive (E-G) and 10 to extremely comfortable (A-D) or disruptive (E-G). In the
histograms, the frequency of each numerical rating is expressed as a percentage of the total number of responses (n). Insets: measures of the
mean, median, standard deviation (SD), and skewness (symmetry) to describe the location and variability of the distributions.
centage of participants who would spend at most D 100,
D 200, D 300, D 400, D 500, or over D 500 were respec-
tively 17.7, 27.4, 14.5, 1.6, 17.7, and 8.1% (n = 62).
The remaining 12.9% of the participants did not specify
a monetary value but provided additional explanations:
a few respondents could not judge the monetary value
of smart glasses (n = 3) while another indicated that
more experience with these devices was needed to
make a precise decision (n = 1). Based on the comments
gathered from all participants, the monetary value of
smart glasses depended on its efficacy in managing PD
symptoms (n = 5) and participants were therefore will-
ing to pay more if smart glasses could truly improve
their quality of life (n = 6); however, several partic-
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Table 1
Patient requested features for smart glasses
Features Number of
responses
Function Improves gait 10
Maintains balance 4
Increase confidence 3
No side effects 3
Decreases freezing of gait 2
Helps standing up 1
Facilitates independence 1
Design Easy to operate 5
Comfortable to wear 4
Accommodate prescription lenses 4
Aesthetically pleasing 3
Durable/Sturdy 2
Hands-free operation 1
Application GPS/navigation guidance 5
Instructions/alerts to improve movement 5
Detect gait/balance problems 5
Auditory cues 4
Visual cues 2
Agenda/reminders/to do lists 2
(Emergency) calls/contacts 2
Object/ QR code recognition 1
Log daily activities 1
Virtual reality physiotherapy 1
ipants were adamant that medical insurance should
reimburse them at least in part (n = 4).
Parkinson’s disease in daily life
To prioritize smart glasses applications in terms of
their usefulness in activities of daily living, we asked
participants to quantify the extent to which PD impedes
them in various setting on a scale of 0 to 10 (0 corre-
sponding to not at all and 10 to extremely disruptive).
The ratings distributions for home, work, and in daily
life all peaked around 7-8 and were left skewed
(Fig. 1E-G), indicating that PD was prohibitive in most
aspects of life. No significant differences were found
between the distributions of the different settings. In
their comments, participants reported that motor prob-
lems (n = 6) and tasks requiring multitasking, fine
motor skills, and endurance (e.g. cycling, housework,
walking outside, etc.) (n = 4) particularly affected their
quality of life, with some participants no longer able
to work at all (n = 4). Nonetheless, many participants
were determined to stay active (n = 6) and independent
(n = 2) in spite of the disease. According to one patient:
“It is inevitable that [PD is] prevalent in everyday life;
however, I will not let this prevent me from pushing
boundaries and overcoming limitations by continuing
to pursue all that interests me (e.g. driving, traveling,
dancing, singing, sports, etc.). ”
Table 2
Situations that exacerbate the symptoms of Parkinson’s disease
Exacerbating situations Number of
responses
Movement Long periods of sitting or
lying down
10
Initiating new movement 6
Standing up 4
Transitional movements 3
Stopping movement 2
Walking backwards 2
Walking outside 2
Multitasking 2
Standing still 1
Spatial obstruction Narrow spaces and passages 6
Turns 5
Busy areas 2
Complex crossings 1
Doors 1
Mental state Fatigue 4
Stress 1
Fear 1
Distractions 1
Time of the day Morning 8
Medication wearing off 7
Unpredictable 3
Afternoon 2
Late afternoon/early evening 2
Evening 2
Night 1
All day 1
We further asked the participants to list the symp-
toms they experience and specific situations that
exacerbate these symptoms. The respondents most
frequently cited motor impairments, including gait
disability (80.6%), balance impairment (72.6%), freez-
ing (37.1%), tremor (43.5%), poor coordination
(33.9%), and rigidity (9.7%) (n = 62). 45.2% of the
respondents also complained about sleep disturbances
and 6.5 reported cognitive impairments. As shown in
Table 2, gait or freezing can be triggered by specific
movements, spatial obstructions, mental states, and
time of the day. For example, participants recounted
motor complications after long periods of sitting or
lying down, standing up, initiating new movements,
and transitioning between movements (e.g. stepping
off a bicycle). Notably challenging were tight turns,
narrow spaces, doors, and complicated crossings.
Mornings were especially problematic and symptoms
became more prominent when medication began to
wear off. Fatigue, stress, fear, and distractions further
exacerbated motor performance. Only 12.9% of all the
participants specifically reported little to no problems
with gait or freezing on a daily basis.
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Fig. 2. Use of mobile technology. (A-C) Ratings of how comfortable people with PD were in using mobile technologies. The rating scale
ranged from 0 to 10, with 0 corresponding to completely uncomfortable and 10 to extremely comfortable. (A) The frequency of each numerical
rating is expressed as a percentage of the total number of respondents (n = 61). Inset: measures of the mean, median, standard deviation (SD)
and skewness to describe the location and variability of the distribution. (B-C) The comfort ratings as a function of (B) age (n = 60) and (C)
disease progression (n = 59). (D-E) The frequency with which people with PD use mobile devices as a function of (D) age (n = 60) and (E)
disease progression (n = 59). For each box and whiskers plot, the central mark corresponds to the median and the edges to the 25th and the
75th percentiles. The whiskers encompass the most extreme data points which are not considered to be outliers; outliers are individually
plotted.
Treatments for Parkinson’s disease
To assess which existing therapies could be incorpo-
rated into smart glasses, we asked participants which
therapies they currently use. The majority undergo
physiotherapy (76.7%) and take medication (76.7%)
while 6.7% use DBS (n = 60). Some participants also
follow exercise programs (e.g. boxing, Parkfit pro-
gram, and Cesar therapy, 10.0%), speech therapy
(3.3%) and light-therapy (3.3%). Overall, people living
with PD “ . . . long for a way to maintain dopamine
levels without all the side effects.”
Besides traditional PD therapies, 46.8% of all par-
ticipants (n = 62) use external cues or cueing devices
to improve their gait and balance, including canes
(22.6%), auditory metronomes (provided by an exter-
nal device or self-made, 16.1%), music (listening or
singing, 11.3%), stripes on the floor (8.1%), counting
(6.5%), and lasers (1.6%). Participants also rated the
effectiveness of each cue they used on a scale of 0
to 10 (0 corresponding to severely worsens and 10 to
significantly improves), resulting in average ratings of
7.6 ± 1.3 for the cane (n = 13), 7.4 ± 1.1 for the audi-
tory metronome (n = 10), 7.5 ± 0.8 for music (n = 8),
7.0 ± 1.0 for stripes on the floor (n = 7), 6.6 ± 1.1 for
counting (n = 5), and 7.0 ± 1.7 for lasers (n = 3). Some
participants reported that their symptoms were not
severe enough yet to use cueing (16.1%) or that they
were, up until now, unfamiliar with cueing strategies
(14.5%). Others used walking supports such as rolla-
tors (19.4%), Nordic walking poles (4.8%), and scooter
mobiles (3.2%).Should smartglassesbeable toprovide
cueing therapy, the participants preferred to control for
themselves when the cues are given: on a scale of 0
to 10 (0 corresponding to completely automatic and
10 to completely manual), 66.7% choose a rating of 5
or greater (n = 61). Nevertheless, the respondents sug-
gested that a combination of manual and automatic
control might be best, depending on the situation.
Use of mobile technology
To predict how easily people with PD could adapt
to smart glasses, we asked the participants to rate
how comfortable they were in using mobile tech-
nologies (e.g. smart phones and tablets) on a scale
of 0 to 10 (0 corresponding to totally uncomfort-
able and 10 to extremely comfortable). 57.4% of the
respondents (n = 61) reported a comfort level of 6
or above (Fig. 2A). These ratings showed a signif-
icant inverse correlation with the participants’ age
(rs = −0.45, p < 0.001) but not with the number of years
they had PD (Fig. 2B-C). 74.6% of the respondents
(n = 61) reported using mobile devices in some capac-
ity: 45.9 % on a daily basis, 18.0% 1–5 times a week,
and 11.5% less than once per week. The frequency
of mobile device usage was also significantly corre-
lated with the age of the patient (rs = 0.43, p < 0.001)
Y. Zhao et al. / Guidelines for Developing Smart Glass Apps 375
but not with how long they lived with PD (Fig. 2D-E).
Respondents who never use mobile devices (24.6%)
commented that they were more interested in other
activities (n = 1), had poor eyesight (n = 1), disliked
the sensory experience of using such devices (n = 1),
or did not own any mobile devices (n = 1). In the
open comments, the respondents particularly singled
out the iPad (n = 3) and iPhone (n = 2) (Apple, Cuper-
tino, CA, USA) as useful for researching hobbies,
keeping in touch with family and friends, and work
related activities (e.g. note taking, reading documents,
business communication, administration, organizing
events, etc.). Notably, one participant reported: “my
iPad has become a part of my brain.”
Other health issues
Preexisting health conditions may preclude some
people with PD from using smart glasses. In fact,
57.4% of the respondents (n = 61) reported medi-
cal conditions besides PD, including cardiovascular
(e.g. high blood pressure, heart attack, and infarcts,
n = 12), musculoskeletal (e.g. osteoporosis, arthritis,
tendonitis, hip problems, back pains, scoliosis, and cer-
vical stenosis, n = 11), neurodegenerative (e.g. Lewy
body dementia and dystonia, n = 6) and pulmonary
(e.g. chronic obstructive pulmonary disease, n = 5)
diseases and other problems related to chronic pain
(n = 3), diabetes (n = 3), the spine (n = 3), and cancer
(n = 2). In addition, participants also reported vision
and hearing problems that may preclude the use of
some audiovisual capabilities of smart glasses. Specif-
ically, 75.4% of the respondents (n = 61) required
spectacles (prescription or reading glasses) and 16.4%
suffered from some form of visual impairment. On the
other hand, 67.2% of the respondents (n = 61) reported
no hearing problems while 18.0% suffered from deaf-
ness and 13.1% required hearing aids.
DISCUSSION
Recommended applications
As the effects of PD permeate almost every aspect of
life, an overarching wish amongst the participants was
to regain their independence and self-confidence. In
particular, gait and balance impairments afflict most
people with PD and have the most impact on their
quality of life [8]. With its sensor and feedback capa-
bilities, smart glasses may help by detecting when
motor fluctuations occur, alerting the patient to cor-
rect this behavior, and providing support via visual
or auditory cues, instructional videos, or step by step
verbal instructions. The glasses may even be able to
predict when the patient might require assistance and
take precautionary actions based on situations known
to exacerbate PD (Table 2) or a log of daily activities.
Smart glasses might also support existing PD ther-
apies. For example, users could receive reminders
to take their medication, meet with their physician,
get more light exposure, or exercise. Physiotherapy
and exercise apps could further promote and motivate
physical activity by guiding users through different
movement exercises while tracking their performance
and adjusting the therapy accordingly. Verbally guided
relaxation exercises, on the other hand, may help relax
the patient’s state of mind while gaming apps could
stimulate cognitive abilities. Finally, speech therapy
apps could alert the user to speak louder, provide exter-
nal cues to facilitate speech production, or find the
appropriate words to finish a sentence. All the afore-
mentioned possibilities for smart glasses apps remain
to be developed and thoroughly tested.
Requirements and constraints
Given that most people with PD are above the
age of 50 and have visual impairments, smart glasses
must accommodate prescription glasses and be easy
to operate. Based on the enthusiasm amongst the sur-
vey respondents toward the iPad, a simple and natural
interface that recognizes broad gestures (versus pre-
cise tapping) would help users to navigate the controls.
For people with tremor, hands-free operation could be
achieved through speech recognition; however, users
with speech impediments might require alternative
ways to communicate with smart glasses such as eye
tracking or winking.
In proposing to use smart glasses as an every-
day assistive device, one should also consider its
potentially harmful side effects. First, with respect to
external cueing, complicated situations that demand
increased cognitive processes do indeed aggravate gait
impairments in PD [23, 24]; however, external cueing
has also been shown to facilitate double task walking
[25]. In principle, cueing training could be imple-
mented using smart glass technology and as such
facilitate conditions for goal-based exercise training
to improve gait and gait-related activities for people
with PD [26]. The choice of an appropriate cue as
well as when to give the cue is however nontrivial and
warrants further exploration [26]. Ideally, users should
be able to personalize the apps to accommodate their
symptoms, preferences (i.e. automatic versus manual
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cueing, alerts on or off, etc.), and comfort level with
the device.
Second, chronic exposure to blue light (a portion
of the visible spectrum ranging from 380 to 500 nm
in wavelength), as emitted by light-emitting diode
(LED) based video displays, can lead to damage
of retinal structures via photochemical mechanisms
[27–30]. Moreover, the usage of LED displays such as
eReaders in the evening can negatively affect sleep, cir-
cadian rhythm, and daytime alertness [31] through the
suppression of melatonin release [32–34] and a shift in
the circadian clock [32, 35]. To minimize disruptions
to the retina and circadian rhythm, manufacturers of
smart glasses must carefully tune the spectral power
distribution of these devices [36], possibly through
blue-light filters or by adapting the spectral distribu-
tion throughout the day or according to the frequency
of use.
Third, given the prevalence of cardiovascular and
musculoskeletal diseases amongst people with PD,
physicians and physiotherapists should be involved in
assessing the suitability of certain apps (e.g. movement
training or exercise apps) for these individuals, perhaps
through e-prescriptions (i.e. downloading apps from
an app store via prescriptions). The data collected by
the embedded sensors and daily activity logs on the
smart glasses may also allow clinicians to remotely
monitor the progress and symptoms of their patients.
The results of this and similar data mining initiatives
with other wearable devices (e.g. Michael J. Fox Foun-
dation’s collaboration with Intel) could accelerate PD
research and validation of new therapeutics [37].
Lastly, a potential side effect of taking PD
medication is a propensity to engage in reward seeking
obsessive compulsive behaviors (e.g. hoarding, shop-
ping, eating, and gambling) [38–40]. People with PD
must be advised of such risks when using smart glasses
and caretakers and healthcare professionals should be
vigilant of any addictive activities stemming from its
use.
Limitations of the study
Due to the inherent nature of online self-completed
questionnaires, there are several issues to consider in
the interpretation of the results, namely self-selection
bias and trustworthiness of the responses. People
already proficient with or interested in technology will
be more likely to take part in the online survey; how-
ever, these individuals are also more likely to adopt
smart glasses in clinical practice. In that regard, self-
selection is less critical in the short-term; however,
further work is needed to examine the perceptions of
other patient groups, including elderly or less edu-
cated patients without regular access to the internet.
It is furthermore impossible to fully demonstrate the
trustworthiness of the responses. For example, the
survey could have been completed by or with help
from a partner or family member as opposed to the
person with PD; nevertheless, this should not detract
from the value of responses as caretakers often play
an integral role in the care of individuals with PD
and their decision-making. To verify the veracity of
the responses, we checked the answers for a sub-
set of 10 participants during subsequent face-to-face
interviews.
Future outlook
Smart glasses possess the potential to empower
people with PD by providing everyday assistance in
the self-management of their symptoms. Through this
study, we uncovered many useful applications of smart
glasses for people with PD and established some
requirements and constraints for its design. Partici-
pants who responded to our survey were generally
positive about smart glasses and their usage of current
mobile technologies suggests that smart glasses may
become as integral to their lives as smart phones and
tablets. However, more research is necessary to ensure
the safety, efficacy, usability, and social acceptance of
smart glasses.
Although unaddressed in our survey, privacy and
social stigma will undoubtedly become major points
of contention. In the United States and the United
Kingdom, where the Google Glass is currently avail-
able, lawmakers, citizens, and business owners have
already raised concerns about privacy, road safety,
violation of intellectual property, and breach of con-
fidentiality. Social stigma may also plague people
with PD, who feel especially self-conscious [41],
while wearing smart glasses in public. However, as
smart glasses become less conspicuous and estab-
lish valuable therapeutic benefits for people with
PD, its legal and social acceptance should also
evolve.
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